Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Lemoyneon Oct 07, 2024 12:04pm
63 Views
Post# 36256201

RE:Reposted - may explain the large BID versus ASK

RE:Reposted - may explain the large BID versus ASKThis is why this board is so bad. People posting and reposting garbage.

1. Those 2013 news are the result of a person diving head first in a rabbit hole trying to find value where there is none. And some of the information in that post underscores the OG poster disability to do decent due diligence. You don't have to search deep to find out that LABS has a history of posting news concerning new partners that either never realize any material gain or fizzle out to be non significant in the grand order of things (STADA, Germany and Brazil).

2. The reason they paid that debt is simply because it came due september 15th. There was no "suddenly" involved. They disclosed that information during Q2 cc.

3. Also, LABS will report nothing in October if it sticks to its modus operandi, which is to report financials at the last possible minute, mid november.
<< Previous
Bullboard Posts
Next >>